• Activated ONLY inside cancer cells
  • Providing effective tumor destruction
  • Effective prevention of cancer recurrence
  • NO observed side-effects
  • A long-term therapy
  • Patient-oriented therapy with high probability of success

BioCancell Therapeutics, Inc. has developed a Patient-Oriented, Targeted Therapy for diagnosis and treatment of many types of cancer.

Patient-Oriented means only those diagnosed with H19, a gene present in tumors of most cancer patients, are eligible for treatment. Targeted Therapy means the H19 gene drives the synthesis of a toxin only inside the cancer cells, effectively destroying them without damage to surrounding tissue or body systems.

Safe, highly-targeted, effective and usable long-term - it's a break-through!

 

Keep in touch!

Enter your email address here for corporate updates and alerts

BioCancell Therapeutics keeps your information private. Privacy Policy